Companies

Cartesian Therapeutics, Inc. (RNAC) SEC filings

CIK 0001453687 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)2.8 M26.0 M
Net income (USD)35.4 M-68.9 M
Diluted EPS (USD/shares)-5.02-49.760.1

Latest filings

FiledFormDescriptionPeriod
2026-09-298-K8-K items 7.01,8.01,9.012026-09-29
2026-08-13SCHEDULE 13GSCHEDULE 13G
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-07-22SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-178-K8-K items 5.072026-06-12
2026-06-09144144
2026-06-098-K8-K items 7.01,9.012026-06-09
2026-06-02144144
2026-05-268-K8-K items 1.01,2.03,3.02,5.02,7.01,9.012026-05-22
2026-05-06SCHEDULE 13G/ASCHEDULE 13G/A
2026-04-30S-8S-8
2026-04-3010-Q10-Q2026-03-31
2026-04-308-K8-K items 2.02,9.012026-04-30
2026-04-28DEF 14ADEF 14A2025-12-31
2026-04-28DEFA14ADEFA14A
2026-04-064STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES2026-04-02
2026-04-064STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES2026-04-02
2026-04-02SCHEDULE 13D/ASCHEDULE 13D/A
2026-03-308-K8-K items 5.022026-03-26
2026-03-134FORM 42026-03-13
2026-03-13SCHEDULE 13GSCHEDULE 13G
2026-03-0910-K10-K2025-12-31
2026-03-098-K8-K items 2.02,9.012026-03-09
2026-02-05SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 4 356, 8-K 172, 3 50, 10-Q 31, SC 13D/A 29, CORRESP 19, SC 13G 19, 144 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=RNAC (0.002 USD), /gw/filings/filings?ticker=RNAC&form=8-K, /gw/filings/facts?ticker=RNAC&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange